1. CpG methylation at the USF-binding site mediates cell-specific transcription of human ascorbate transporter SVCT2 exon 1a.
- Author
-
Qiao H and May JM
- Subjects
- Azacitidine analogs & derivatives, Azacitidine pharmacology, CCAAT-Binding Factor metabolism, Cell Line, Cell Line, Tumor, CpG Islands physiology, Decitabine, Exons drug effects, Humans, Methylation, Promoter Regions, Genetic, CpG Islands drug effects, Dinucleoside Phosphates metabolism, Sodium-Coupled Vitamin C Transporters biosynthesis, Upstream Stimulatory Factors metabolism
- Abstract
SVCT2 (sodium-vitamin C co-transporter 2) is the major transporter mediating vitamin C uptake in most organs. Its expression is driven by two promoters (CpG-poor exon 1a promoter and CpG-rich exon 1b promoter). In the present study, we mapped discrete elements within the proximal CpG-poor promoter responsible for exon 1a transcription. We identified two E boxes for USF (upstream stimulating factor) binding and one Y box for NF-Y (nuclear factor Y) binding. We show further that NF-Y and USF bind to the exon 1a promoter in a co-operative manner, amplifying the binding of each to the promoter, and is absolutely required for the full activity of the exon 1a promoter. The analysis of the CpG site located at the upstream USF-binding site in the promoter showed a strong correlation between expression and demethylation. It was also shown that exon 1a transcription was induced in cell culture treated with the demethylating agent decitabine. The specific methylation of this CpG site impaired both the binding of USF and the formation of the functional NF-Y-USF complex as well as promoter activity, suggesting its importance for cell-specific transcription. Thus CpG methylation at the upstream USF-binding site functions in establishing and maintaining cell-specific transcription from the CpG-poor SVCT2 exon 1a promoter.
- Published
- 2011
- Full Text
- View/download PDF